OJK Bancassurance Regulations: Compliance Guide for Banks and Insurers in Indonesia

Navigating Indonesia's bancassurance regulatory landscape

Published: 5 September 2024
10 min read

Indonesia's Financial Services Authority (OJK) has established comprehensive regulations governing bancassurance activities. Banks and insurance companies must comply with these regulations covering product distribution, sales practices, consumer protection, and reporting requirements.

OJK Regulatory Framework for Bancassurance

OJK regulates bancassurance through multiple regulations covering: partnership agreements between banks and insurers, product approval processes, sales practice requirements, commission disclosure, consumer protection, and reporting obligations. Non-compliance can result in sanctions and partnership suspension.

Key Compliance Requirements

Banks must ensure proper licensing of sales staff, provide adequate product training, maintain transparent commission structures, implement cooling-off periods, handle complaints effectively, and submit regular reports to OJK. Insurance companies must ensure products meet suitability requirements for bank customers.

Common Compliance Challenges

Organizations struggle with: tracking sales staff certification and training status, ensuring product suitability assessments are completed, managing commission transparency requirements, maintaining audit trails for regulatory examinations, and generating OJK reports accurately and on time.

How Technology Ensures Compliance

The right bancassurance platform embeds OJK compliance requirements directly into workflows. Look for solutions that enforce certification checks before sales, automate suitability assessments, maintain complete audit trails, track cooling-off periods, and generate regulatory reports in OJK-required formats. BRIDGE is one platform designed with these compliance capabilities for the Indonesian market.

FAQ

FAQ

OJK can impose sanctions including written warnings, fines, suspension of bancassurance activities, and revocation of partnership approvals. Both the bank and insurer may face regulatory action.